RSS   Newsletter   Contact   Advertise with us
Post Online Media

Mission Therapeutics appoints non-executive chairman

Mission TherapeuticsMission Therapeutics, a drug discovery company, announces that Colin Goddard has been appointed as non-executive chairman from January 1, 2017.
Article continues below

READ MORE Protagonist Therapeutics appoints Lewis T. Williams to board

Prior to joining Mission Therapeutics, Dr. Goddard was Chief Executive Officer of OSI Pharmaceuticals. He joined the company as a research scientist in 1989, becoming CEO in 1998.

Dr. Goddard currently serves as Chairman & CEO of U.S.-based Biotech company, BlinkBio, Inc and as a Director on the boards of Endocyte Inc. He was formerly a Director at Human Genome Sciences Inc.

Dr. Goddard obtained his PhD in cancer pharmacology from the University of Aston in Birmingham, UK and worked at the National Cancer Institute, Bethesda, MD, before joining OSI.

 LATEST MOVES FROM United Kingdom 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy